NORTHERN TRUST CORP - THE ONCOLOGY INSTITUTE INC ownership

THE ONCOLOGY INSTITUTE INC's ticker is and the CUSIP is 68236X100. A total of 41 filers reported holding THE ONCOLOGY INSTITUTE INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of THE ONCOLOGY INSTITUTE INC
ValueSharesWeighting
Q3 2023$62,423
+135.8%
44,588
-7.3%
0.00%
Q2 2023$26,470
-85.1%
48,110
-81.7%
0.00%
Q1 2023$177,866
-58.1%
262,378
+1.9%
0.00%
Q4 2022$424,702
-64.1%
257,395
+0.8%
0.00%
Q3 2022$1,183,000
+62.3%
255,349
+77.4%
0.00%
Q2 2022$729,000
+465.1%
143,921
+696.7%
0.00%
Q1 2022$129,00018,0650.00%
Other shareholders
THE ONCOLOGY INSTITUTE INC shareholders Q4 2022
NameSharesValueWeighting ↓
Triatomic Management LP 517,479$853,8400.72%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 104,400$1720.25%
Prosight Management, LP 275,561$454,6760.25%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,360,052$5,544,0860.12%
Redmile Group, LLC 1,583,158$2,612,2110.11%
Alpine Global Management, LLC 46,326$760.02%
Saba Capital Management, L.P. 174,513$287,9460.00%
FMR LLC 12,001,982$19,803,2700.00%
Leucadia National 192,452$317,5460.00%
BANK OF AMERICA CORP /DE/ 31,995$52,7920.00%
View complete list of THE ONCOLOGY INSTITUTE INC shareholders